Article Figures & Data
Figures
- FIGURE 1.
Correlation between EF-1 and EF-2 in control subjects and patients with CAC and CCC (opioid group excluded). Note good correlation between 2 EFs, with r = 0.73 (P < 0.0001). Solid line shows regression; dashed line shows line of identity.
- FIGURE 2.
Mean ± SD for first (EF-1) and second (EF-2) GBEF in control, CAC, and CCC groups. EF-1 and EF-2 values are not significantly different within groups (P > 0.05) but are significantly low in CAC (P < 0.0001) and CCC (P < 0.0003) when compared with control subjects.
Tables
- TABLE 1
Demography, EFs, Time Interval Between EF-1 aand EF-2, Duration of CCK-8 Infusion, and Final Diagnosis in 52 Patients
Subject no. Age (y) Sex Weight (kg) GBS EF-1 EF-2 Interval (mo) Cause of low EF Final Dx CCK-8 infusion duration 1 54 F 67 No 5 5 0.1 CAC CAC 3 and 3 min 2 49 F 66 No 5 5 0.3 CAC CAC 3 and 3 min 3 33 F No 32 26 0.8 CAC CAC 3 and 3 min 4 45 M 156 No 3 14 1 CAC CAC 10 and 10 min 5 33 F 75 No 4 31 3 CAC CAC 3 and 10 min 6 48 F 68 No 11 7 4 CAC CAC 3 and 3 min 7 43 F No 11 26 8 CAC CAC 3 and 3 min 8 45 F No 7 6 8 CAC CAC 3 and 3 min 9 31 F 82 No 33 27 9 CAC CAC 3 and 3 min 10 63 M No 12 19 11 CAC CAC 3 and 3 min 11 38 M 70 No 12 10 12 CAC CAC 3 and 3 min 12 58 F 69 No 20 12 18 CAC CAC 3 and 10 min 13 33 M No 33 19 23 CAC CAC 3 and 3 min 14 77 F 82 No 42 44 24 CAC CAC 3 and 10 min 15 47 F 85 No 32 11 24 CAC CAC 3 and 3 min 16 56 F No 19 2 26 CAC CAC 3 and 3 min 17 54 F No 24 25 27 CAC CAC 3 and 3 min 18 49 F No 50 2 33 CAC CAC 3 and 3 min 19 51 F 145 No 32 14 44 CAC CAC 3 and 10 min 20 49 F No 6 12 48 CAC CAC 3 and 3 min 21 36 F No 62 26 48 CAC CAC 3 and 3 min 22 62 F 95 No 10 15 48 CAC CAC 3 and 3 min 23 84 F No 70 20 60 CAC CAC 3 and 3 min 24 74 F 64 No 14 26 98 CAC CAC 3 and 3 min 25 34 F 113 No 91 33 98 CAC CAC 3 and 3 min 26 43 F 68 No 8 18 168 CAC CAC 3 and 10 min 27 59 F 73 No 11 0 168 CAC CAC 3 and 10 min 28 78 F Yes 3 1 0.1 CCC CCC 3 and 3 min 29 72 M 77 Yes 25 12 3 CCC CCC 3 and 3 min 30 37 M 111 Yes 12 5 11 CCC CCC 3 and 3 min 31 80 F Yes 13 21 31 CCC CCC 3 and 3 min 32 79 F 69 Yes 61 94 35 N/A CCC 3 and 3 min 33 69 F Yes 11 32 79 CCC CCC 3 and 3 min 34 29 F No 7 74 1 Opioid Normal 3 and 3 min 35 62 M No 9 58 1 Opioid Normal 3 and 3 min 36 46 F Yes 3 72 13 Opioid Normal 3 and 3 min 37 49 F 71 No 18 36 38 Opioid Normal 3 and 3 min 38 84 F 125 Yes 43 5 42 Opioid Normal 3 and 3 min 39 49 F 64 No 9 94 144 Opioid Normal 3 and 10 min 40 38 F No 54 59 1 N/A Normal 3 and 3 min 41 45 M 148 No 68 88 5 N/A Normal 3 and 3 min 42 40 F 113 No 94 92 6 N/A Normal 10 and 10 min 43 50 F 95 No 59 85 11 N/A Normal 3 and 3 min 44 39 F 82 No 36 84 12 N/A Normal 3 and 10 min 45 29 F No 46 35 14 N/A Normal 3 and 3 min 46 63 F 80 No 92 50 24 N/A Normal 3 and 3 min 47 50 F No 89 83 25 N/A Normal 3 and 3 min 48 47 M 85 No 85 90 49 N/A Normal 3 and 10 min 49 81 F 66 No 83 85 48 N/A Normal 3 and 3 min 50 46 F No 52 67 66 N/A Normal 3 and 3 min 51 56 M 118 No 72 62 156 N/A Normal 3 and 10 min 52 47 F 72 No 40 81 177 N/A Normal 3 and 10 min GBS = gallstone; Dx = diagnosis; N/A = not applicable.
Normal GBEF is ≥35% with 3-min and ≥50% with 10-min infusion of CCK-8.
Category Normal (n = 13) CAC (n = 27) CCC (n = 6) Opioid (n = 6) Time between first and second study (mo) 45.7 ± 57.2 37.5 ± 46.1 26.5 ± 29.5 39.83 ± 54.02 Study number 1 2 1 2 1 2 1 2 GBEF Mean 66.9 73.9 24.4 16.9 20.8 27.5 14.8 56.5 SD 20.5 17.7 22.3 10.9 20.9 34.5 14.6 31.7
